nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—atherosclerosis	0.482	0.728	CbGaD
Nabumetone—PTGS2—atherosclerosis	0.181	0.273	CbGaD
Nabumetone—MPO—superior mesenteric artery—atherosclerosis	0.0379	0.498	CbGeAlD
Nabumetone—MPO—artery—atherosclerosis	0.00405	0.0533	CbGeAlD
Nabumetone—MPO—endothelium—atherosclerosis	0.00342	0.045	CbGeAlD
Nabumetone—PTGS2—leg—atherosclerosis	0.00336	0.0441	CbGeAlD
Nabumetone—MPO—blood vessel—atherosclerosis	0.00316	0.0415	CbGeAlD
Nabumetone—PTGS2—hindlimb—atherosclerosis	0.003	0.0394	CbGeAlD
Nabumetone—PTGS2—appendage—atherosclerosis	0.00257	0.0338	CbGeAlD
Nabumetone—PTGS1—artery—atherosclerosis	0.00192	0.0253	CbGeAlD
Nabumetone—PTGS2—artery—atherosclerosis	0.00184	0.0242	CbGeAlD
Nabumetone—PTGS1—endothelium—atherosclerosis	0.00162	0.0214	CbGeAlD
Nabumetone—MPO—connective tissue—atherosclerosis	0.00162	0.0213	CbGeAlD
Nabumetone—PTGS2—endothelium—atherosclerosis	0.00155	0.0204	CbGeAlD
Nabumetone—PTGS1—blood vessel—atherosclerosis	0.0015	0.0197	CbGeAlD
Nabumetone—PTGS2—blood vessel—atherosclerosis	0.00143	0.0188	CbGeAlD
Nabumetone—MPO—cardiovascular system—atherosclerosis	0.00141	0.0185	CbGeAlD
Nabumetone—Melatonin—MPO—atherosclerosis	0.000887	0.388	CrCbGaD
Nabumetone—MPO—liver—atherosclerosis	0.000871	0.0115	CbGeAlD
Nabumetone—PTGS1—connective tissue—atherosclerosis	0.000768	0.0101	CbGeAlD
Nabumetone—PTGS2—connective tissue—atherosclerosis	0.000734	0.00965	CbGeAlD
Nabumetone—PTGS1—cardiovascular system—atherosclerosis	0.000668	0.00878	CbGeAlD
Nabumetone—Melatonin—ESR1—atherosclerosis	0.000665	0.291	CrCbGaD
Nabumetone—PTGS2—cardiovascular system—atherosclerosis	0.000639	0.0084	CbGeAlD
Nabumetone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000631	0.00413	CcSEcCtD
Nabumetone—Angina pectoris—Niacin—atherosclerosis	0.000626	0.0041	CcSEcCtD
Nabumetone—Depression—Simvastatin—atherosclerosis	0.000622	0.00408	CcSEcCtD
Nabumetone—Pancreatitis—Pravastatin—atherosclerosis	0.00062	0.00406	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000618	0.00405	CcSEcCtD
Nabumetone—Sweating increased—Pravastatin—atherosclerosis	0.000616	0.00404	CcSEcCtD
Nabumetone—Angina pectoris—Pravastatin—atherosclerosis	0.000616	0.00404	CcSEcCtD
Nabumetone—Jaundice—Simvastatin—atherosclerosis	0.000608	0.00398	CcSEcCtD
Nabumetone—Flatulence—Rosuvastatin—atherosclerosis	0.000606	0.00397	CcSEcCtD
Nabumetone—Erectile dysfunction—Niacin—atherosclerosis	0.000592	0.00388	CcSEcCtD
Nabumetone—Dysuria—Pravastatin—atherosclerosis	0.000591	0.00388	CcSEcCtD
Nabumetone—PTGS1—adipose tissue—atherosclerosis	0.000589	0.00775	CbGeAlD
Nabumetone—Erectile dysfunction—Pravastatin—atherosclerosis	0.000582	0.00382	CcSEcCtD
Nabumetone—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000577	0.00378	CcSEcCtD
Nabumetone—Weight increased—Pravastatin—atherosclerosis	0.000576	0.00377	CcSEcCtD
Nabumetone—Weight decreased—Pravastatin—atherosclerosis	0.000572	0.00375	CcSEcCtD
Nabumetone—Erythema multiforme—Lovastatin—atherosclerosis	0.000566	0.00371	CcSEcCtD
Nabumetone—PTGS2—adipose tissue—atherosclerosis	0.000563	0.0074	CbGeAlD
Nabumetone—Depression—Pravastatin—atherosclerosis	0.000562	0.00368	CcSEcCtD
Nabumetone—Angioedema—Rosuvastatin—atherosclerosis	0.000562	0.00368	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000559	0.00366	CcSEcCtD
Nabumetone—Jaundice—Niacin—atherosclerosis	0.000558	0.00366	CcSEcCtD
Nabumetone—Stomatitis—Niacin—atherosclerosis	0.000558	0.00366	CcSEcCtD
Nabumetone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000556	0.00364	CcSEcCtD
Nabumetone—Erythema multiforme—Ezetimibe—atherosclerosis	0.000555	0.00364	CcSEcCtD
Nabumetone—Myocardial infarction—Pravastatin—atherosclerosis	0.000553	0.00362	CcSEcCtD
Nabumetone—Jaundice—Pravastatin—atherosclerosis	0.00055	0.0036	CcSEcCtD
Nabumetone—Chills—Lovastatin—atherosclerosis	0.000537	0.00352	CcSEcCtD
Nabumetone—Cough—Rosuvastatin—atherosclerosis	0.000537	0.00352	CcSEcCtD
Nabumetone—Erythema multiforme—Simvastatin—atherosclerosis	0.000529	0.00347	CcSEcCtD
Nabumetone—Alopecia—Lovastatin—atherosclerosis	0.000529	0.00347	CcSEcCtD
Nabumetone—Alopecia—Ezetimibe—atherosclerosis	0.000519	0.0034	CcSEcCtD
Nabumetone—Haemoglobin—Niacin—atherosclerosis	0.000517	0.00339	CcSEcCtD
Nabumetone—Haemorrhage—Niacin—atherosclerosis	0.000514	0.00337	CcSEcCtD
Nabumetone—Flatulence—Lovastatin—atherosclerosis	0.000513	0.00336	CcSEcCtD
Nabumetone—Confusional state—Rosuvastatin—atherosclerosis	0.000506	0.00332	CcSEcCtD
Nabumetone—Flatulence—Ezetimibe—atherosclerosis	0.000504	0.0033	CcSEcCtD
Nabumetone—Chills—Simvastatin—atherosclerosis	0.000502	0.00329	CcSEcCtD
Nabumetone—Visual impairment—Niacin—atherosclerosis	0.000495	0.00325	CcSEcCtD
Nabumetone—Alopecia—Simvastatin—atherosclerosis	0.000495	0.00324	CcSEcCtD
Nabumetone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000491	0.00322	CcSEcCtD
Nabumetone—Tremor—Lovastatin—atherosclerosis	0.000488	0.0032	CcSEcCtD
Nabumetone—Visual impairment—Pravastatin—atherosclerosis	0.000488	0.0032	CcSEcCtD
Nabumetone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000483	0.00317	CcSEcCtD
Nabumetone—Flatulence—Simvastatin—atherosclerosis	0.00048	0.00315	CcSEcCtD
Nabumetone—Tinnitus—Niacin—atherosclerosis	0.000479	0.00314	CcSEcCtD
Nabumetone—Erythema multiforme—Pravastatin—atherosclerosis	0.000479	0.00314	CcSEcCtD
Nabumetone—CYP1A2—liver—atherosclerosis	0.000477	0.00627	CbGeAlD
Nabumetone—Angioedema—Lovastatin—atherosclerosis	0.000476	0.00312	CcSEcCtD
Nabumetone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000474	0.00311	CcSEcCtD
Nabumetone—Anaemia—Ezetimibe—atherosclerosis	0.000472	0.0031	CcSEcCtD
Nabumetone—Tinnitus—Pravastatin—atherosclerosis	0.000472	0.00309	CcSEcCtD
Nabumetone—Malaise—Lovastatin—atherosclerosis	0.00047	0.00308	CcSEcCtD
Nabumetone—Vertigo—Lovastatin—atherosclerosis	0.000468	0.00307	CcSEcCtD
Nabumetone—Angioedema—Ezetimibe—atherosclerosis	0.000467	0.00306	CcSEcCtD
Nabumetone—Leukopenia—Lovastatin—atherosclerosis	0.000466	0.00306	CcSEcCtD
Nabumetone—Chills—Niacin—atherosclerosis	0.000461	0.00302	CcSEcCtD
Nabumetone—Malaise—Ezetimibe—atherosclerosis	0.000461	0.00302	CcSEcCtD
Nabumetone—Arrhythmia—Niacin—atherosclerosis	0.000459	0.00301	CcSEcCtD
Nabumetone—Tremor—Simvastatin—atherosclerosis	0.000457	0.00299	CcSEcCtD
Nabumetone—Alopecia—Niacin—atherosclerosis	0.000454	0.00298	CcSEcCtD
Nabumetone—Chills—Pravastatin—atherosclerosis	0.000454	0.00298	CcSEcCtD
Nabumetone—Insomnia—Rosuvastatin—atherosclerosis	0.000454	0.00297	CcSEcCtD
Nabumetone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000452	0.00296	CcSEcCtD
Nabumetone—Arrhythmia—Pravastatin—atherosclerosis	0.000452	0.00296	CcSEcCtD
Nabumetone—Palpitations—Ezetimibe—atherosclerosis	0.000452	0.00296	CcSEcCtD
Nabumetone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000451	0.00295	CcSEcCtD
Nabumetone—Anaemia—Simvastatin—atherosclerosis	0.00045	0.00295	CcSEcCtD
Nabumetone—Alopecia—Pravastatin—atherosclerosis	0.000447	0.00293	CcSEcCtD
Nabumetone—Cough—Ezetimibe—atherosclerosis	0.000446	0.00292	CcSEcCtD
Nabumetone—Angioedema—Simvastatin—atherosclerosis	0.000445	0.00292	CcSEcCtD
Nabumetone—Anxiety—Lovastatin—atherosclerosis	0.000442	0.0029	CcSEcCtD
Nabumetone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000442	0.00289	CcSEcCtD
Nabumetone—Hypertension—Ezetimibe—atherosclerosis	0.000441	0.00289	CcSEcCtD
Nabumetone—Flatulence—Niacin—atherosclerosis	0.000441	0.00289	CcSEcCtD
Nabumetone—Malaise—Simvastatin—atherosclerosis	0.00044	0.00288	CcSEcCtD
Nabumetone—Tension—Niacin—atherosclerosis	0.000439	0.00288	CcSEcCtD
Nabumetone—Discomfort—Lovastatin—atherosclerosis	0.000438	0.00287	CcSEcCtD
Nabumetone—Vertigo—Simvastatin—atherosclerosis	0.000438	0.00287	CcSEcCtD
Nabumetone—Leukopenia—Simvastatin—atherosclerosis	0.000436	0.00286	CcSEcCtD
Nabumetone—Nervousness—Niacin—atherosclerosis	0.000435	0.00285	CcSEcCtD
Nabumetone—Flatulence—Pravastatin—atherosclerosis	0.000434	0.00285	CcSEcCtD
Nabumetone—Dry mouth—Lovastatin—atherosclerosis	0.000434	0.00284	CcSEcCtD
Nabumetone—Tension—Pravastatin—atherosclerosis	0.000432	0.00283	CcSEcCtD
Nabumetone—Discomfort—Ezetimibe—atherosclerosis	0.00043	0.00282	CcSEcCtD
Nabumetone—Constipation—Rosuvastatin—atherosclerosis	0.000429	0.00281	CcSEcCtD
Nabumetone—Confusional state—Lovastatin—atherosclerosis	0.000429	0.00281	CcSEcCtD
Nabumetone—Nervousness—Pravastatin—atherosclerosis	0.000428	0.0028	CcSEcCtD
Nabumetone—Dry mouth—Ezetimibe—atherosclerosis	0.000426	0.00279	CcSEcCtD
Nabumetone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000425	0.00279	CcSEcCtD
Nabumetone—Confusional state—Ezetimibe—atherosclerosis	0.000421	0.00276	CcSEcCtD
Nabumetone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000417	0.00273	CcSEcCtD
Nabumetone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000416	0.00273	CcSEcCtD
Nabumetone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000414	0.00271	CcSEcCtD
Nabumetone—Anxiety—Simvastatin—atherosclerosis	0.000413	0.00271	CcSEcCtD
Nabumetone—Tremor—Pravastatin—atherosclerosis	0.000413	0.00271	CcSEcCtD
Nabumetone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00041	0.00269	CcSEcCtD
Nabumetone—Discomfort—Simvastatin—atherosclerosis	0.00041	0.00269	CcSEcCtD
Nabumetone—Angioedema—Niacin—atherosclerosis	0.000409	0.00268	CcSEcCtD
Nabumetone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000409	0.00268	CcSEcCtD
Nabumetone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000408	0.00268	CcSEcCtD
Nabumetone—Anaemia—Pravastatin—atherosclerosis	0.000407	0.00267	CcSEcCtD
Nabumetone—Anorexia—Lovastatin—atherosclerosis	0.000405	0.00266	CcSEcCtD
Nabumetone—Angioedema—Pravastatin—atherosclerosis	0.000403	0.00264	CcSEcCtD
Nabumetone—Vertigo—Niacin—atherosclerosis	0.000402	0.00263	CcSEcCtD
Nabumetone—Syncope—Niacin—atherosclerosis	0.000401	0.00263	CcSEcCtD
Nabumetone—Confusional state—Simvastatin—atherosclerosis	0.000401	0.00263	CcSEcCtD
Nabumetone—Leukopenia—Niacin—atherosclerosis	0.000401	0.00263	CcSEcCtD
Nabumetone—Urticaria—Rosuvastatin—atherosclerosis	0.000399	0.00261	CcSEcCtD
Nabumetone—Oedema—Simvastatin—atherosclerosis	0.000398	0.00261	CcSEcCtD
Nabumetone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000398	0.00261	CcSEcCtD
Nabumetone—Malaise—Pravastatin—atherosclerosis	0.000397	0.0026	CcSEcCtD
Nabumetone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000397	0.0026	CcSEcCtD
Nabumetone—Vertigo—Pravastatin—atherosclerosis	0.000396	0.00259	CcSEcCtD
Nabumetone—Palpitations—Niacin—atherosclerosis	0.000395	0.00259	CcSEcCtD
Nabumetone—PTGS2—liver—atherosclerosis	0.000395	0.00519	CbGeAlD
Nabumetone—Leukopenia—Pravastatin—atherosclerosis	0.000394	0.00258	CcSEcCtD
Nabumetone—Loss of consciousness—Niacin—atherosclerosis	0.000393	0.00258	CcSEcCtD
Nabumetone—Cough—Niacin—atherosclerosis	0.000391	0.00256	CcSEcCtD
Nabumetone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000389	0.00255	CcSEcCtD
Nabumetone—Naproxen—PTGS2—atherosclerosis	0.000386	0.169	CrCbGaD
Nabumetone—Insomnia—Lovastatin—atherosclerosis	0.000385	0.00252	CcSEcCtD
Nabumetone—Cough—Pravastatin—atherosclerosis	0.000385	0.00252	CcSEcCtD
Nabumetone—Paraesthesia—Lovastatin—atherosclerosis	0.000382	0.0025	CcSEcCtD
Nabumetone—Hypertension—Pravastatin—atherosclerosis	0.00038	0.00249	CcSEcCtD
Nabumetone—Anorexia—Simvastatin—atherosclerosis	0.000379	0.00248	CcSEcCtD
Nabumetone—Dyspnoea—Lovastatin—atherosclerosis	0.000379	0.00248	CcSEcCtD
Nabumetone—Insomnia—Ezetimibe—atherosclerosis	0.000377	0.00247	CcSEcCtD
Nabumetone—Paraesthesia—Ezetimibe—atherosclerosis	0.000375	0.00245	CcSEcCtD
Nabumetone—Dyspepsia—Lovastatin—atherosclerosis	0.000374	0.00245	CcSEcCtD
Nabumetone—Anxiety—Pravastatin—atherosclerosis	0.000374	0.00245	CcSEcCtD
Nabumetone—Dry mouth—Niacin—atherosclerosis	0.000373	0.00244	CcSEcCtD
Nabumetone—Dyspnoea—Ezetimibe—atherosclerosis	0.000372	0.00244	CcSEcCtD
Nabumetone—Discomfort—Pravastatin—atherosclerosis	0.000371	0.00243	CcSEcCtD
Nabumetone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00037	0.00242	CcSEcCtD
Nabumetone—Decreased appetite—Lovastatin—atherosclerosis	0.00037	0.00242	CcSEcCtD
Nabumetone—Dyspepsia—Ezetimibe—atherosclerosis	0.000367	0.00241	CcSEcCtD
Nabumetone—Fatigue—Lovastatin—atherosclerosis	0.000367	0.0024	CcSEcCtD
Nabumetone—Anaphylactic shock—Niacin—atherosclerosis	0.000365	0.00239	CcSEcCtD
Nabumetone—Oedema—Niacin—atherosclerosis	0.000365	0.00239	CcSEcCtD
Nabumetone—Constipation—Lovastatin—atherosclerosis	0.000364	0.00238	CcSEcCtD
Nabumetone—Confusional state—Pravastatin—atherosclerosis	0.000363	0.00238	CcSEcCtD
Nabumetone—Decreased appetite—Ezetimibe—atherosclerosis	0.000363	0.00238	CcSEcCtD
Nabumetone—Asthenia—Rosuvastatin—atherosclerosis	0.00036	0.00236	CcSEcCtD
Nabumetone—Insomnia—Simvastatin—atherosclerosis	0.00036	0.00236	CcSEcCtD
Nabumetone—Oedema—Pravastatin—atherosclerosis	0.00036	0.00236	CcSEcCtD
Nabumetone—Anaphylactic shock—Pravastatin—atherosclerosis	0.00036	0.00236	CcSEcCtD
Nabumetone—Fatigue—Ezetimibe—atherosclerosis	0.00036	0.00236	CcSEcCtD
Nabumetone—Shock—Niacin—atherosclerosis	0.000359	0.00235	CcSEcCtD
Nabumetone—Paraesthesia—Simvastatin—atherosclerosis	0.000357	0.00234	CcSEcCtD
Nabumetone—Constipation—Ezetimibe—atherosclerosis	0.000357	0.00234	CcSEcCtD
Nabumetone—Pruritus—Rosuvastatin—atherosclerosis	0.000355	0.00233	CcSEcCtD
Nabumetone—Dyspnoea—Simvastatin—atherosclerosis	0.000355	0.00232	CcSEcCtD
Nabumetone—Hyperhidrosis—Niacin—atherosclerosis	0.000353	0.00231	CcSEcCtD
Nabumetone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000352	0.00231	CcSEcCtD
Nabumetone—Feeling abnormal—Lovastatin—atherosclerosis	0.00035	0.0023	CcSEcCtD
Nabumetone—Dyspepsia—Simvastatin—atherosclerosis	0.00035	0.00229	CcSEcCtD
Nabumetone—Anorexia—Niacin—atherosclerosis	0.000348	0.00228	CcSEcCtD
Nabumetone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000348	0.00228	CcSEcCtD
Nabumetone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000348	0.00228	CcSEcCtD
Nabumetone—Decreased appetite—Simvastatin—atherosclerosis	0.000346	0.00227	CcSEcCtD
Nabumetone—Naproxen—ALB—atherosclerosis	0.000344	0.151	CrCbGaD
Nabumetone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000344	0.00225	CcSEcCtD
Nabumetone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000343	0.00225	CcSEcCtD
Nabumetone—Fatigue—Simvastatin—atherosclerosis	0.000343	0.00225	CcSEcCtD
Nabumetone—Anorexia—Pravastatin—atherosclerosis	0.000343	0.00225	CcSEcCtD
Nabumetone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000341	0.00224	CcSEcCtD
Nabumetone—Constipation—Simvastatin—atherosclerosis	0.00034	0.00223	CcSEcCtD
Nabumetone—Urticaria—Lovastatin—atherosclerosis	0.000338	0.00221	CcSEcCtD
Nabumetone—Body temperature increased—Lovastatin—atherosclerosis	0.000336	0.0022	CcSEcCtD
Nabumetone—Abdominal pain—Lovastatin—atherosclerosis	0.000336	0.0022	CcSEcCtD
Nabumetone—Dizziness—Rosuvastatin—atherosclerosis	0.000332	0.00217	CcSEcCtD
Nabumetone—Urticaria—Ezetimibe—atherosclerosis	0.000331	0.00217	CcSEcCtD
Nabumetone—Insomnia—Niacin—atherosclerosis	0.00033	0.00216	CcSEcCtD
Nabumetone—Abdominal pain—Ezetimibe—atherosclerosis	0.00033	0.00216	CcSEcCtD
Nabumetone—Body temperature increased—Ezetimibe—atherosclerosis	0.00033	0.00216	CcSEcCtD
Nabumetone—Paraesthesia—Niacin—atherosclerosis	0.000328	0.00215	CcSEcCtD
Nabumetone—Feeling abnormal—Simvastatin—atherosclerosis	0.000328	0.00215	CcSEcCtD
Nabumetone—Dyspnoea—Niacin—atherosclerosis	0.000326	0.00213	CcSEcCtD
Nabumetone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000325	0.00213	CcSEcCtD
Nabumetone—Insomnia—Pravastatin—atherosclerosis	0.000325	0.00213	CcSEcCtD
Nabumetone—Somnolence—Niacin—atherosclerosis	0.000325	0.00213	CcSEcCtD
Nabumetone—Paraesthesia—Pravastatin—atherosclerosis	0.000323	0.00212	CcSEcCtD
Nabumetone—Dyspepsia—Niacin—atherosclerosis	0.000322	0.00211	CcSEcCtD
Nabumetone—Dyspnoea—Pravastatin—atherosclerosis	0.000321	0.0021	CcSEcCtD
Nabumetone—Decreased appetite—Niacin—atherosclerosis	0.000317	0.00208	CcSEcCtD
Nabumetone—Dyspepsia—Pravastatin—atherosclerosis	0.000317	0.00207	CcSEcCtD
Nabumetone—Rash—Rosuvastatin—atherosclerosis	0.000316	0.00207	CcSEcCtD
Nabumetone—Dermatitis—Rosuvastatin—atherosclerosis	0.000316	0.00207	CcSEcCtD
Nabumetone—Urticaria—Simvastatin—atherosclerosis	0.000316	0.00207	CcSEcCtD
Nabumetone—Abdominal pain—Simvastatin—atherosclerosis	0.000314	0.00206	CcSEcCtD
Nabumetone—Body temperature increased—Simvastatin—atherosclerosis	0.000314	0.00206	CcSEcCtD
Nabumetone—Headache—Rosuvastatin—atherosclerosis	0.000314	0.00206	CcSEcCtD
Nabumetone—Hypersensitivity—Lovastatin—atherosclerosis	0.000313	0.00205	CcSEcCtD
Nabumetone—Decreased appetite—Pravastatin—atherosclerosis	0.000313	0.00205	CcSEcCtD
Nabumetone—Fatigue—Pravastatin—atherosclerosis	0.00031	0.00203	CcSEcCtD
Nabumetone—Constipation—Pravastatin—atherosclerosis	0.000308	0.00202	CcSEcCtD
Nabumetone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000307	0.00201	CcSEcCtD
Nabumetone—Asthenia—Lovastatin—atherosclerosis	0.000305	0.002	CcSEcCtD
Nabumetone—Pruritus—Lovastatin—atherosclerosis	0.000301	0.00197	CcSEcCtD
Nabumetone—Asthenia—Ezetimibe—atherosclerosis	0.000299	0.00196	CcSEcCtD
Nabumetone—Gastrointestinal pain—Niacin—atherosclerosis	0.000299	0.00196	CcSEcCtD
Nabumetone—Nausea—Rosuvastatin—atherosclerosis	0.000298	0.00195	CcSEcCtD
Nabumetone—Feeling abnormal—Pravastatin—atherosclerosis	0.000296	0.00194	CcSEcCtD
Nabumetone—Pruritus—Ezetimibe—atherosclerosis	0.000295	0.00193	CcSEcCtD
Nabumetone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000294	0.00193	CcSEcCtD
Nabumetone—Hypersensitivity—Simvastatin—atherosclerosis	0.000293	0.00192	CcSEcCtD
Nabumetone—Diarrhoea—Lovastatin—atherosclerosis	0.000291	0.00191	CcSEcCtD
Nabumetone—Urticaria—Niacin—atherosclerosis	0.00029	0.0019	CcSEcCtD
Nabumetone—Abdominal pain—Niacin—atherosclerosis	0.000289	0.00189	CcSEcCtD
Nabumetone—Body temperature increased—Niacin—atherosclerosis	0.000289	0.00189	CcSEcCtD
Nabumetone—Urticaria—Pravastatin—atherosclerosis	0.000286	0.00187	CcSEcCtD
Nabumetone—Asthenia—Simvastatin—atherosclerosis	0.000285	0.00187	CcSEcCtD
Nabumetone—Diarrhoea—Ezetimibe—atherosclerosis	0.000285	0.00187	CcSEcCtD
Nabumetone—Body temperature increased—Pravastatin—atherosclerosis	0.000284	0.00186	CcSEcCtD
Nabumetone—Abdominal pain—Pravastatin—atherosclerosis	0.000284	0.00186	CcSEcCtD
Nabumetone—Pruritus—Simvastatin—atherosclerosis	0.000281	0.00184	CcSEcCtD
Nabumetone—Dizziness—Lovastatin—atherosclerosis	0.000281	0.00184	CcSEcCtD
Nabumetone—Dizziness—Ezetimibe—atherosclerosis	0.000276	0.00181	CcSEcCtD
Nabumetone—Diarrhoea—Simvastatin—atherosclerosis	0.000272	0.00178	CcSEcCtD
Nabumetone—Vomiting—Lovastatin—atherosclerosis	0.00027	0.00177	CcSEcCtD
Nabumetone—Hypersensitivity—Niacin—atherosclerosis	0.000269	0.00176	CcSEcCtD
Nabumetone—Rash—Lovastatin—atherosclerosis	0.000268	0.00176	CcSEcCtD
Nabumetone—Dermatitis—Lovastatin—atherosclerosis	0.000268	0.00176	CcSEcCtD
Nabumetone—Headache—Lovastatin—atherosclerosis	0.000266	0.00175	CcSEcCtD
Nabumetone—Vomiting—Ezetimibe—atherosclerosis	0.000265	0.00174	CcSEcCtD
Nabumetone—Hypersensitivity—Pravastatin—atherosclerosis	0.000265	0.00174	CcSEcCtD
Nabumetone—Dizziness—Simvastatin—atherosclerosis	0.000263	0.00172	CcSEcCtD
Nabumetone—Rash—Ezetimibe—atherosclerosis	0.000263	0.00172	CcSEcCtD
Nabumetone—Dermatitis—Ezetimibe—atherosclerosis	0.000263	0.00172	CcSEcCtD
Nabumetone—Asthenia—Niacin—atherosclerosis	0.000262	0.00172	CcSEcCtD
Nabumetone—Headache—Ezetimibe—atherosclerosis	0.000261	0.00171	CcSEcCtD
Nabumetone—Pruritus—Niacin—atherosclerosis	0.000258	0.00169	CcSEcCtD
Nabumetone—Asthenia—Pravastatin—atherosclerosis	0.000258	0.00169	CcSEcCtD
Nabumetone—Pruritus—Pravastatin—atherosclerosis	0.000254	0.00167	CcSEcCtD
Nabumetone—Vomiting—Simvastatin—atherosclerosis	0.000253	0.00166	CcSEcCtD
Nabumetone—Nausea—Lovastatin—atherosclerosis	0.000253	0.00166	CcSEcCtD
Nabumetone—Rash—Simvastatin—atherosclerosis	0.000251	0.00164	CcSEcCtD
Nabumetone—Dermatitis—Simvastatin—atherosclerosis	0.000251	0.00164	CcSEcCtD
Nabumetone—Diarrhoea—Niacin—atherosclerosis	0.00025	0.00164	CcSEcCtD
Nabumetone—Headache—Simvastatin—atherosclerosis	0.000249	0.00163	CcSEcCtD
Nabumetone—Nausea—Ezetimibe—atherosclerosis	0.000248	0.00162	CcSEcCtD
Nabumetone—Diarrhoea—Pravastatin—atherosclerosis	0.000246	0.00161	CcSEcCtD
Nabumetone—Dizziness—Niacin—atherosclerosis	0.000242	0.00158	CcSEcCtD
Nabumetone—Dizziness—Pravastatin—atherosclerosis	0.000238	0.00156	CcSEcCtD
Nabumetone—Nausea—Simvastatin—atherosclerosis	0.000236	0.00155	CcSEcCtD
Nabumetone—Vomiting—Niacin—atherosclerosis	0.000232	0.00152	CcSEcCtD
Nabumetone—Rash—Niacin—atherosclerosis	0.00023	0.00151	CcSEcCtD
Nabumetone—Dermatitis—Niacin—atherosclerosis	0.00023	0.00151	CcSEcCtD
Nabumetone—Headache—Niacin—atherosclerosis	0.000229	0.0015	CcSEcCtD
Nabumetone—Vomiting—Pravastatin—atherosclerosis	0.000229	0.0015	CcSEcCtD
Nabumetone—Rash—Pravastatin—atherosclerosis	0.000227	0.00149	CcSEcCtD
Nabumetone—Dermatitis—Pravastatin—atherosclerosis	0.000227	0.00148	CcSEcCtD
Nabumetone—Headache—Pravastatin—atherosclerosis	0.000225	0.00148	CcSEcCtD
Nabumetone—Nausea—Niacin—atherosclerosis	0.000217	0.00142	CcSEcCtD
Nabumetone—Nausea—Pravastatin—atherosclerosis	0.000214	0.0014	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	5.04e-05	0.000472	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—atherosclerosis	5.04e-05	0.000472	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	4.95e-05	0.000464	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	4.76e-05	0.000446	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	4.71e-05	0.000441	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	4.71e-05	0.000441	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.7e-05	0.00044	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.67e-05	0.000438	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.65e-05	0.000435	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.61e-05	0.000431	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.54e-05	0.000425	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	4.42e-05	0.000414	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCG8—atherosclerosis	4.4e-05	0.000412	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LTA4H—atherosclerosis	4.4e-05	0.000412	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCG1—atherosclerosis	4.38e-05	0.00041	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.35e-05	0.000407	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	4.32e-05	0.000405	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	4.31e-05	0.000403	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	4.25e-05	0.000398	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	4.2e-05	0.000393	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	4.16e-05	0.000389	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	4.16e-05	0.000389	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—FABP4—atherosclerosis	4.12e-05	0.000386	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LCAT—atherosclerosis	4.12e-05	0.000386	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.1e-05	0.000384	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	4.08e-05	0.000382	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA4—atherosclerosis	4.04e-05	0.000379	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	4.01e-05	0.000375	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	4e-05	0.000374	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP7A1—atherosclerosis	3.97e-05	0.000372	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	3.92e-05	0.000367	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOA4—atherosclerosis	3.83e-05	0.000359	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.79e-05	0.000355	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.7e-05	0.000347	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP27A1—atherosclerosis	3.67e-05	0.000344	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.66e-05	0.000342	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.62e-05	0.000339	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.53e-05	0.00033	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.51e-05	0.000329	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.51e-05	0.000329	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.51e-05	0.000329	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.51e-05	0.000329	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA2—atherosclerosis	3.48e-05	0.000326	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLA2G2A—atherosclerosis	3.48e-05	0.000326	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALOX5AP—atherosclerosis	3.48e-05	0.000326	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALOX15—atherosclerosis	3.48e-05	0.000326	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCG1—atherosclerosis	3.48e-05	0.000326	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.47e-05	0.000325	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCG5—atherosclerosis	3.44e-05	0.000322	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.43e-05	0.000322	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.43e-05	0.000321	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.37e-05	0.000315	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.35e-05	0.000314	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LPA—atherosclerosis	3.32e-05	0.000311	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOA2—atherosclerosis	3.3e-05	0.000309	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—FABP4—atherosclerosis	3.27e-05	0.000306	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LCAT—atherosclerosis	3.27e-05	0.000306	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—BGN—atherosclerosis	3.22e-05	0.000301	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.21e-05	0.000301	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA4—atherosclerosis	3.21e-05	0.000301	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.19e-05	0.000299	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA5—atherosclerosis	3.18e-05	0.000298	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	3.16e-05	0.000296	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP7A1—atherosclerosis	3.15e-05	0.000295	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	3.11e-05	0.000291	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.09e-05	0.00029	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.09e-05	0.00029	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLA2G1B—atherosclerosis	3.06e-05	0.000287	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	3.06e-05	0.000286	CbGpPWpGaD
Nabumetone—PTGS2—Disease—BGN—atherosclerosis	3.05e-05	0.000286	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.03e-05	0.000284	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.01e-05	0.000281	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3e-05	0.000281	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3e-05	0.000281	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.99e-05	0.00028	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALOX5—atherosclerosis	2.96e-05	0.000277	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.94e-05	0.000275	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP27A1—atherosclerosis	2.92e-05	0.000273	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLTP—atherosclerosis	2.87e-05	0.000269	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.87e-05	0.000269	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.85e-05	0.000267	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.8e-05	0.000262	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALOX15—atherosclerosis	2.76e-05	0.000259	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALOX5AP—atherosclerosis	2.76e-05	0.000259	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLA2G2A—atherosclerosis	2.76e-05	0.000259	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA2—atherosclerosis	2.76e-05	0.000259	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.73e-05	0.000256	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCG5—atherosclerosis	2.73e-05	0.000256	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.73e-05	0.000255	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.66e-05	0.00025	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.66e-05	0.000249	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CST3—atherosclerosis	2.66e-05	0.000249	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NAMPT—atherosclerosis	2.66e-05	0.000249	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.64e-05	0.000248	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.64e-05	0.000247	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LIPC—atherosclerosis	2.64e-05	0.000247	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPA—atherosclerosis	2.64e-05	0.000247	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.63e-05	0.000246	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOC3—atherosclerosis	2.62e-05	0.000246	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LDLR—atherosclerosis	2.61e-05	0.000244	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.57e-05	0.00024	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—BGN—atherosclerosis	2.55e-05	0.000239	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CETP—atherosclerosis	2.55e-05	0.000238	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.54e-05	0.000237	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA5—atherosclerosis	2.53e-05	0.000237	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NAMPT—atherosclerosis	2.52e-05	0.000236	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.49e-05	0.000233	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.49e-05	0.000233	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOC3—atherosclerosis	2.49e-05	0.000233	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LDLR—atherosclerosis	2.47e-05	0.000231	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.46e-05	0.00023	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.46e-05	0.00023	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SCARB1—atherosclerosis	2.44e-05	0.000228	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLA2G1B—atherosclerosis	2.43e-05	0.000228	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.41e-05	0.000225	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HSPA1B—atherosclerosis	2.39e-05	0.000223	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.38e-05	0.000223	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.38e-05	0.000223	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.37e-05	0.000222	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALOX5—atherosclerosis	2.35e-05	0.00022	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.32e-05	0.000217	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NCF1—atherosclerosis	2.31e-05	0.000216	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMGCR—atherosclerosis	2.3e-05	0.000216	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CYBA—atherosclerosis	2.17e-05	0.000203	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.17e-05	0.000203	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PARP1—atherosclerosis	2.13e-05	0.000199	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NAMPT—atherosclerosis	2.11e-05	0.000197	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.1e-05	0.000196	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LIPC—atherosclerosis	2.09e-05	0.000196	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOC3—atherosclerosis	2.08e-05	0.000195	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.08e-05	0.000194	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.07e-05	0.000194	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LDLR—atherosclerosis	2.07e-05	0.000194	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCA1—atherosclerosis	2.05e-05	0.000192	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CETP—atherosclerosis	2.02e-05	0.000189	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.98e-05	0.000186	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.97e-05	0.000184	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SCARB1—atherosclerosis	1.94e-05	0.000181	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.88e-05	0.000176	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FABP4—atherosclerosis	1.85e-05	0.000173	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LCAT—atherosclerosis	1.85e-05	0.000173	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMGCR—atherosclerosis	1.83e-05	0.000171	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA4—atherosclerosis	1.82e-05	0.00017	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.78e-05	0.000167	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—atherosclerosis	1.76e-05	0.000165	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.7e-05	0.000159	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOB—atherosclerosis	1.69e-05	0.000158	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.65e-05	0.000154	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—atherosclerosis	1.64e-05	0.000154	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCA1—atherosclerosis	1.63e-05	0.000153	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.62e-05	0.000152	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LPL—atherosclerosis	1.61e-05	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOB—atherosclerosis	1.6e-05	0.00015	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.58e-05	0.000148	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GPX1—atherosclerosis	1.57e-05	0.000147	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.56e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.56e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA2—atherosclerosis	1.56e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.56e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.54e-05	0.000145	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.54e-05	0.000144	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CD36—atherosclerosis	1.53e-05	0.000143	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LPL—atherosclerosis	1.53e-05	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPA—atherosclerosis	1.49e-05	0.00014	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCG—atherosclerosis	1.48e-05	0.000139	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—atherosclerosis	1.45e-05	0.000136	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BGN—atherosclerosis	1.44e-05	0.000135	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.43e-05	0.000134	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA5—atherosclerosis	1.43e-05	0.000134	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARA—atherosclerosis	1.42e-05	0.000133	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—atherosclerosis	1.4e-05	0.000131	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.39e-05	0.00013	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AGT—atherosclerosis	1.38e-05	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.38e-05	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—atherosclerosis	1.37e-05	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.36e-05	0.000127	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOE—atherosclerosis	1.35e-05	0.000126	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.35e-05	0.000126	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.35e-05	0.000126	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOB—atherosclerosis	1.34e-05	0.000125	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFB—atherosclerosis	1.34e-05	0.000125	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAV1—atherosclerosis	1.34e-05	0.000125	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA1—atherosclerosis	1.33e-05	0.000125	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.33e-05	0.000125	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—atherosclerosis	1.3e-05	0.000122	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOE—atherosclerosis	1.28e-05	0.00012	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPL—atherosclerosis	1.28e-05	0.00012	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CAV1—atherosclerosis	1.27e-05	0.000119	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOA1—atherosclerosis	1.26e-05	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GPX1—atherosclerosis	1.25e-05	0.000117	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.23e-05	0.000115	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.22e-05	0.000114	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CD36—atherosclerosis	1.21e-05	0.000114	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.19e-05	0.000112	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—atherosclerosis	1.19e-05	0.000112	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.19e-05	0.000111	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LIPC—atherosclerosis	1.19e-05	0.000111	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOC3—atherosclerosis	1.18e-05	0.00011	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—atherosclerosis	1.18e-05	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LDLR—atherosclerosis	1.17e-05	0.00011	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—INS—atherosclerosis	1.15e-05	0.000108	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—atherosclerosis	1.15e-05	0.000108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CETP—atherosclerosis	1.14e-05	0.000107	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARA—atherosclerosis	1.13e-05	0.000106	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.1e-05	0.000103	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AGT—atherosclerosis	1.09e-05	0.000102	CbGpPWpGaD
Nabumetone—PTGS2—Disease—INS—atherosclerosis	1.09e-05	0.000102	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOE—atherosclerosis	1.07e-05	0.0001	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.07e-05	9.98e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAV1—atherosclerosis	1.06e-05	9.94e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA1—atherosclerosis	1.06e-05	9.92e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—atherosclerosis	1.06e-05	9.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.03e-05	9.68e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—atherosclerosis	1.01e-05	9.47e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SERPINE1—atherosclerosis	1e-05	9.4e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CG—atherosclerosis	9.67e-06	9.05e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—atherosclerosis	9.58e-06	8.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—atherosclerosis	9.33e-06	8.74e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.33e-06	8.73e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—atherosclerosis	9.25e-06	8.66e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCA1—atherosclerosis	9.22e-06	8.63e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—INS—atherosclerosis	9.15e-06	8.57e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—atherosclerosis	8.39e-06	7.86e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—atherosclerosis	8.03e-06	7.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.91e-06	7.41e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOB—atherosclerosis	7.57e-06	7.09e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.37e-06	6.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPL—atherosclerosis	7.23e-06	6.77e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX1—atherosclerosis	7.06e-06	6.61e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CD36—atherosclerosis	6.87e-06	6.44e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—atherosclerosis	6.84e-06	6.4e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK3—atherosclerosis	6.53e-06	6.12e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.51e-06	6.1e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARA—atherosclerosis	6.39e-06	5.98e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—atherosclerosis	6.34e-06	5.93e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AGT—atherosclerosis	6.19e-06	5.79e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOE—atherosclerosis	6.06e-06	5.68e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAV1—atherosclerosis	6.01e-06	5.62e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA1—atherosclerosis	5.99e-06	5.61e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.47e-06	5.12e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—atherosclerosis	5.28e-06	4.94e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—INS—atherosclerosis	5.18e-06	4.85e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—atherosclerosis	4.78e-06	4.47e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—atherosclerosis	4.75e-06	4.45e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—atherosclerosis	4.65e-06	4.35e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—atherosclerosis	4.54e-06	4.25e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—atherosclerosis	4.41e-06	4.13e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.15e-06	3.89e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—atherosclerosis	3.69e-06	3.45e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—atherosclerosis	2.09e-06	1.96e-05	CbGpPWpGaD
